Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System

Publisher： Karger

E-ISSN： 1660-3818|40|1|44-48

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.40, Iss.1, 2013-01, pp. : 44-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 5, 2009-08 ,pp. : 309-315

Karger

Access to resources Recommend Favorite

Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 3, 2015-05 ,pp. : 167-173

Karger

Access to resources Recommend Favorite

Efficacy of the Mirasol pathogen reduction technology system against severe fever with thrombocytopenia syndrome virus (SFTSV)

By  

VOX SANGUINIS, Vol. 109, Iss. 4, 2015-11 ,pp. : 417-419

John Wiley & Sons Inc

Access to resources Recommend Favorite

Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?

By  

TRANSFUSION, Vol. 55, Iss. 8, 2015-08 ,pp. : 1900-1908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1745-1751

John Wiley & Sons Inc

Access to resources Recommend Favorite